Rabbit Polyclonal NAT8 antibody. Suitable for IHC-P, WB and reacts with Human, Mouse samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human NAT8 aa 50 to C-terminus.
View Alternative Names
CML1, GLA, TSC501, NAT8, N-acetyltransferase 8, Acetyltransferase 2, Camello-like protein 1, Cysteinyl-conjugate N-acetyltransferase, ATase2, CCNAT
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NAT8 antibody (AB197793)
Immunohistochemical analysis of paraffin-embedded Human cervical tissue labeling NAT8 using ab197793 at a 1/50 dilution.
- WB
Supplier Data
Western blot - Anti-NAT8 antibody (AB197793)
All lanes:
Western blot - Anti-NAT8 antibody (ab197793) at 1/238 dilution
Lane 1:
mouse kidney tissue lysate at 40 µg
Lane 2:
mouse liver tissue lysate at 40 µg
Predicted band size: 26 kDa
false
Exposure time: 20s
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
{NAT8} participates in the detoxification process by transferring an acetyl group to endogenous amines and drugs. Acetylation by {NAT8} facilitates these compounds' excretion serving a protective role against potentially hazardous substances. {NAT8} does not generally form part of a larger protein complex but its enzymatic function is reliant upon the presence of acetyl-CoA as a cofactor.
Pathways
The acetylation function of {NAT8} integrates into metabolic and detoxification pathways. It plays a role in the biotransformation pathway operating with enzymes like CYP450 that handle phase I and phase II metabolism of various xenobiotics. In this capacity {NAT8} works alongside other acetyltransferases contributing to the comprehensive process of making drugs and toxins more hydrophilic.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
eLife 13: PubMed39255019
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com